TARA   $2.38  3.93% Market Closed

Protara Therapeutics Inc
Total Cash 89.58M
totalCashPerShare 4.342
EBITDA -43.90M
Total Debt 4.98M
quickRatio 15.861
currentRatio 16.327
Total Revenue
debtToEquity 5.414
Revenue/Share
ROA -0.2811
ROE -0.45905
grossProfits
freeCashflow -20.31M
operatingCashflow -33.33M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -30.75M
forwardPE -0.765625
floatShares 15.17M
sharesOutstanding 20.63M
sharesShort 2.32M
sharesShortPriorMonth 2.10M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.51%
Short Ratio help_outline 19.71%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue 4.462
Price To Book help_outline 0.55
earningsQuarterlyGrowth
netIncomeToCommon -40.69M
trailingEps -3.03%
forwardEps -3.20%
enterpriseToEbitda 0.70
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.52 3Q 2024
institutionsCount 44
lastUpdated Nov. 7, 2024, 3:26 a.m.